Skip to content

A Clinical Study of the efficacy and safety of semiconductor laser therapeutic apparatus for the debridement of periodontal pocket

A Clinical Study of the efficacy and safety of semiconductor laser therapeutic apparatus for the debridement of periodontal pocket

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041160
Enrollment
Unknown
Registered
2020-12-19
Start date
2020-12-25
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

experimental group:Laser therapy
control group:Laser therapy

Sponsors

Stomatological Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-60 years old (including 18 and 60 years old), regardless of gender. 2. Patients with periodontitis who need "debridement of the inner wall of periodontal pocket" under local anesthesia with laser therapeutic apparatus (at least one tooth has a probing depth of more than 5 mm, and the alveolar bone absorption exceeds 1 / 3 of the root length; no periodontal endodontic lesions or periodontal endodontic lesions have been treated perfectly). 3. Informed consent has been signed by the patients, guardians or witness.

Exclusion criteria

Exclusion criteria: 1. Mental patients and subjects with cognitive impairment and unable to cooperate. 2. Subjects with pregnancy plan during pregnancy, lactation or nearly one month. 3. Patients with coagulation dysfunction and contraindication of surgery. 4. Patients with pacemakers. 5. Patients with severe immune dysfunction and contraindication of surgery. 6. Patients with severe organic lesions and intolerance to surgery. 7. Patients with obvious infection at the operation site. 8. Subjects with laser cutting tissue in contact with implants. 9. Patients with malignant tumor. 10. Subjects whose routine biochemical indexes are not in the normal range and whose abnormality is clinically significant according to the researcher's judgment. 11. Subjects who had taken antibiotics within one month. 12. Subjects who have participated in clinical trials of other medical devices or drugs within 3 months. 13. Subjects considered unsuitable for the clinical trial.

Design outcomes

Primary

MeasureTime frame
Change in visit depth;

Secondary

MeasureTime frame
Changes of attachment level before and after treatment;Changes of gingival index before and after treatment;Changes of plaque index before and after treatment;Changes of tooth mobility before and after treatment;Disinfection convenience, operation convenience, safety and stability;

Countries

Cnina

Contacts

Public ContactShuhuan Shang

Wuhan University Stomatological Hospital

87292134@qq.com+86 27-87686212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026